Industry Taskforce Aims to Standardize Drug Development Training Practice
The International Academy of Clinical Research (IAoCR) has initiated an independent taskforce of industry experts from the international clinical research industry to create a set of best practice recommendations for effective training of all parties involved in pharmaceutical development and manufacturing.
The document, entitled ‘GxP Training Guidelines’, will contain minimum requirements for best practice in training to help introduce consistent training standards across the industry; something that is currently lacking.
The taskforce comprises members from diverse backgrounds including pharmaceutical companies, contract research organizations and independents from Europe, North America and Asia. The consultation process will be extended to a wider group of individuals and organizations from industry, academia, government and regulators on Aug. 1, 2012. The IAoCR is asking that any interested parties register to receive the draft document by using the webform on www.iaocr.com/gxpt. Details on how to provide feedback will be sent along with the draft document.
CEO at IAoCR, Jacqueline Johnson North says: “We understand that in a complex industry such as ours, different parties will make their own interpretations of the training guidelines. It is crucial that we engage the industry in creating the most cohesive, relevant set of recommendations possible. The more people who review this document and provide feedback, the more valuable it will be. We would like the training guidelines to be applicable to all members of the industry across all sectors and would encourage everyone to get involved.”
The draft of the document, along with information on how to provide feedback in confidence, will be available to view or download from Aug. 1, 2012 on the IAoCR website – www.iaocr.com/gxpt-draft. The deadline for feedback is Sept. 21, 2012. After this time, the taskforce will finalize the guidelines ready for publication in October 2012.
It is hoped that the guidelines will be voluntarily adopted across the industry and that this will provide a global framework for best practice. The taskforce will be undertaking a number of conference presentations from October 2012 and throughout 2013.
For more information, please visit www.iaocr.com.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
